ImmunityBio (IBRX) Acquisitions (2015)
ImmunityBio (IBRX) reported Acquisitions of $1.8 million for Q1 2015.
ImmunityBio (IBRX) Acquisitions (2015) Analysis & Trends
ImmunityBio (IBRX) has 1 years of Acquisitions data on file, last reported at $1.8 million in Q1 2015.
- Acquisitions for Q1 2015 came in at $1.8 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2015 was $1.8 million (changed N/A YoY), and the FY2024 annual result was $1.0 million, changed N/A from the prior year.
- Acquisitions steadied at $1.8 million in Q1 2015 per IBRX's latest filing.
- Over five years, Acquisitions peaked at $1.8 million in Q1 2015 and troughed at $1.8 million in Q1 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | ImmunityBio | 7.55 Bn | 7.17 Bn | 43.97 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2015 | 1.82 Mn |